Pneumonia Diagnostic Global Market Key Developments, Outlook, 2016 Analysis & Forecast to 2022
ReportsWeb.com published “Pneumonia Diagnostic Global Market” from its database. This report Strategic recommendations in key business segments based on the market estimations. This report Supply chain trends mapping the latest technological advancements.
(EMAILWIRE.COM, October 05, 2017 ) According to Publisher, the global Pneumonia Diagnostic market is accounted for $xx million in 2016 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2016 to 2022. Factors such as developing innovative technologies and products, increasing patient awareness and improving productivity of diagnosing pneumonia are boosting the market growth. Advent of new drugs and advance treatment facilitates are going to provide new market opportunities to emerge. However, there is no particular treatment available to detect the pneumonia as its symptoms coincide with diseases like bronchitis, common cold and asthma which are restraining the market growth.
For more information about this report: http://www.reportsweb.com/pneumonia-diagnostic-global-market-outlook-2016-2022
Chest X-ray and CT scan are generally recommended for the diagnosis of pneumonia diagnostics. North America is the largest market due to increasing resistance to multi drugs by microorganisms and increasing geriatric population. Asia Pacific is anticipated to be the fastest growing market owing to prevalence of disease in several countries including India, Japan and Bangladesh. Additionally, high awareness and disposable income are potential growth factors.
Some of the key players in global Pneumonia Diagnostic market are Abbott, Affymetrix, Beckman Coulter Inc, Becton Dickinson, BioMerieux, Bio-Rad, Cepheid, Diamedix, Elitech Group, Qiagen, Siemens, Thermo Fisher Scientific, GlaxoSmithCline and Merck & Co.
Treatments Covered:
-Vaccines
-PCV13
-PPV23
-Antibiotics
-Amoxicillin
-Cephalosporin
-Penicillin
-Tetracycline
-Vancomycin
-Fluoroquinolones
Tests Covered:
-Blood Test
-Bronchoscopy
-Chest X ray
-Chest Computed Tomography (CT) Scan
-Pulse Oximetry
-Pleural Fluid Culture
-Sputum Test
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716602/sample
End Users Covered:
-Clinics
-Diagnostic Centres
-Hospitals
-Commercial/Private Labs
-Other End Users
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
10.1 Abbott
10.2 Affymetrix
10.3 Beckman Coulter Inc
10.4 Becton Dickinson
10.5 bioMerieux
10.6 Bio-Rad
10.7 Cepheid
10.8 Diamedix
10.9 Elitech Group
10.10 Qiagen
10.11 Siemens
10.12 Thermo Fisher Scientific
10.13 GlaxoSmithCline
10.14 Merck & Co
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716602/buying
For more information about this report: http://www.reportsweb.com/pneumonia-diagnostic-global-market-outlook-2016-2022
Chest X-ray and CT scan are generally recommended for the diagnosis of pneumonia diagnostics. North America is the largest market due to increasing resistance to multi drugs by microorganisms and increasing geriatric population. Asia Pacific is anticipated to be the fastest growing market owing to prevalence of disease in several countries including India, Japan and Bangladesh. Additionally, high awareness and disposable income are potential growth factors.
Some of the key players in global Pneumonia Diagnostic market are Abbott, Affymetrix, Beckman Coulter Inc, Becton Dickinson, BioMerieux, Bio-Rad, Cepheid, Diamedix, Elitech Group, Qiagen, Siemens, Thermo Fisher Scientific, GlaxoSmithCline and Merck & Co.
Treatments Covered:
-Vaccines
-PCV13
-PPV23
-Antibiotics
-Amoxicillin
-Cephalosporin
-Penicillin
-Tetracycline
-Vancomycin
-Fluoroquinolones
Tests Covered:
-Blood Test
-Bronchoscopy
-Chest X ray
-Chest Computed Tomography (CT) Scan
-Pulse Oximetry
-Pleural Fluid Culture
-Sputum Test
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001716602/sample
End Users Covered:
-Clinics
-Diagnostic Centres
-Hospitals
-Commercial/Private Labs
-Other End Users
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
Company Profiling
10.1 Abbott
10.2 Affymetrix
10.3 Beckman Coulter Inc
10.4 Becton Dickinson
10.5 bioMerieux
10.6 Bio-Rad
10.7 Cepheid
10.8 Diamedix
10.9 Elitech Group
10.10 Qiagen
10.11 Siemens
10.12 Thermo Fisher Scientific
10.13 GlaxoSmithCline
10.14 Merck & Co
Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001716602/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results